Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.

Newcomer JW, Nasrallah HA, Loebel AD.

J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S1-6.

PMID:
15356414
2.

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.

Nasrallah HA, Newcomer JW.

J Clin Psychopharmacol. 2004 Oct;24(5 Suppl 1):S7-14.

PMID:
15356415
3.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
4.

[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V; Cardiac Safety in Schizophrenia Group.

Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62. French.

PMID:
12506268
5.

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

Meltzer HY, Davidson M, Glassman AH, Vieweg WV.

J Clin Psychiatry. 2002;63 Suppl 9:25-9. Review.

PMID:
12088173
6.
7.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
8.

Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Patel MX, Nikolaou V, David AS.

Psychol Med. 2003 Jan;33(1):83-9.

PMID:
12537039
9.

Effects of atypical antipsychotics on weight and serum lipid levels.

Meyer JM.

J Clin Psychiatry. 2001;62 Suppl 27:27-34; discussion 40-1. Review.

PMID:
11806486
10.

Factors in antipsychotic drug selection: tolerability considerations.

Nasrallah HA.

CNS Spectr. 2003 Nov;8(11 Suppl 2):23-5.

PMID:
14978455
11.

Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.

Diatta T, Blazejewski S, Portier A, Lignot S, Quesnot A, Moore N, Fourrier-R├ęglat A.

Fundam Clin Pharmacol. 2007 Aug;21(4):371-8.

PMID:
17635175
12.

Attitudes of psychiatrists toward antipsychotic depot medication.

Heres S, Hamann J, Kissling W, Leucht S.

J Clin Psychiatry. 2006 Dec;67(12):1948-53.

PMID:
17194274
13.

[Metabolic risk during antipsychotic treatment in patients with schizophrenia].

Rzewuska M.

Psychiatr Pol. 2007 Jul-Aug;41(4):457-72. Review. Polish.

PMID:
18046977
14.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
15.

Metabolic risks and effects of atypical antipsychotic treatment.

Haupt DW, Kane JM.

J Clin Psychiatry. 2007 Oct;68(10):e24.

PMID:
17960957
16.

Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

Newcomer JW.

J Clin Psychiatry. 2004;65 Suppl 18:36-46. Review.

PMID:
15600383
17.

Side effects of atypical antipsychotic drugs.

Ananth J, Parameswaran S, Gunatilake S.

Curr Pharm Des. 2004;10(18):2219-29. Review.

PMID:
15281897
18.

Antipsychotics and the risk of diabetes: a general data review.

Bottai T, Quintin P, Perrin E.

Eur Psychiatry. 2005 Dec;20 Suppl 4:S349-57. Review.

PMID:
16459250
19.

Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.

Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP.

Curr Med Res Opin. 2008 Aug;24(8):2271-82. doi: 10.1185/03007990802250056. Epub 2008 Jun 26.

PMID:
18588748
20.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448

Supplemental Content

Support Center